Advertisement

Topics

2017 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape [Updated: 30032017] Prices from USD $1850

01:28 EDT 20 Jun 2017 | BioPortfolio Reports

Complete report $1,850. nbsp;DataPack test volumes, sales forecasts, supplier shares $1,200. nbsp;The report is available by section, market segment, and can be customtailored to your specific information needs and budget.

This new study from VPGMarketResearchnbsp;contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

Market shares of leading suppliers

Business and technological trends in major markets

Fiveyear test volume and sales forecasts

Market shares of leading competitors

Feature comparison of major analyzers

Strategic profiles of leading market players and startup firms developing innovative products

Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry.nbsp; The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.nbsp; The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of costeffective and automated systems with amplification methods.nbsp; In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.nbsp; Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

France Market Overview

Laboratories performing DNA sequencing and molecular diagnostic testingnbsp;by country and market segment.

Fiveyear test volume and sales projections.

Market Segmentation Analysis

Fiveyear test volume and sales projections:

Infectious Diseasesnbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Forensic Testing

Cancernbsp; nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Paternity Testing/HLA Typing

Genetic Diseasesnbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Others

A comprehensive analysis of the sequencing market by laboratory segment.

Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.

Product/Technology Review

Comparison of the major molecular diagnosticnbsp;analyzers.

Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

Worldwide listings of companies, universities and research centers developing new molecular diagnosticnbsp;technologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in Ramp;D.

nbsp;nbsp; Abbott

nbsp;nbsp; Affymetrix

nbsp;nbsp; Agilent Technologies

nbsp;nbsp; Applied Gene Technologies

nbsp;nbsp; Arca Biopharma

nbsp;nbsp; Beckman Coulter/Danaher

nbsp;nbsp; Becton Dickinson

nbsp;nbsp; Biokit

nbsp;nbsp; BioMerieux

nbsp;nbsp; BioRad

nbsp;nbsp; Biotest

nbsp;nbsp; Cepheid

nbsp;nbsp; CellMark Forensics/LabCorp

nbsp;nbsp; Decode Genetics

nbsp;nbsp; Diadexus

nbsp;nbsp; Eiken

nbsp;nbsp; Elitech Group

nbsp;nbsp; Enzo

nbsp;nbsp; Exact Sciences

nbsp;nbsp; Fujirebio

nbsp;nbsp; Grifols

nbsp;nbsp; Hologic/GenProbe

nbsp;nbsp; Illumina

nbsp;nbsp; Kreatech/Leica

nbsp;nbsp; LiCor Biosciences

nbsp;nbsp; Life Technologies/Thermo Fisher

nbsp;nbsp; Monogram Biosciences

nbsp;nbsp; Myriad Genetics

nbsp;nbsp; OrthoClinical Diagnostics

nbsp;nbsp; Perkin Elmer/Caliper

nbsp;nbsp; Proteome Sciences

nbsp;nbsp; Qiagennbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;

nbsp;nbsp; Roche

nbsp;nbsp; Scienion

nbsp; nbsp; Sequenom

nbsp; nbsp; Shimadzu

nbsp; nbsp; Siemens

nbsp; nbsp; Sierra Molecular

nbsp; nbsp; Takara Bio

nbsp; nbsp; Tecan Group

nbsp;nbsp; Thermo Fisher

Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially significant market appeal during the next five years.

Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Business planning issues and concerns.

Contains 407 pages

Original Article: 2017 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape [Updated: 30032017] Prices from USD $1850

NEXT ARTICLE

More From BioPortfolio on "2017 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape [Updated: 30032017] Prices from USD $1850"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Molecular diagnostics
Molecular diagnostics is a technique used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The tec...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...